EcoNugenics Revenue and Competitors

Location

N/A

Total Funding

Health

Industry

Estimated Revenue & Valuation

  • EcoNugenics's estimated annual revenue is currently $4.5M per year.(i)
  • EcoNugenics's estimated revenue per employee is $189,000

Employee Data

  • EcoNugenics has 24 Employees.(i)
  • EcoNugenics grew their employee count by -11% last year.

EcoNugenics's People

NameTitleEmail/Phone
1
Sr. Marketing DirectorReveal Email/Phone
2
Senior Director Research & Development, Quality AssuranceReveal Email/Phone
3
Director Supply ChainReveal Email/Phone
4
Director SalesReveal Email/Phone
5
Content Strategy ManagerReveal Email/Phone
6
Sales ManagerReveal Email/Phone
7
Senior Marketing ManagerReveal Email/Phone
8
Senior Accountant & Business AnalystReveal Email/Phone
9
Marketing AssociateReveal Email/Phone
10
ControllerReveal Email/Phone
Competitor NameRevenueNumber of EmployeesEmployee GrowthTotal FundingValuation
#1
$14.3M599%N/AN/A
#2
$179.6M5327%N/AN/A
#3
$6.5M303%N/AN/A
#4
$5.3M28-3%N/AN/A
#5
$12.4M5128%N/AN/A
#6
$13.6M56-10%N/AN/A
#7
$6.5M30-12%N/AN/A
#8
$18M746%N/AN/A
#9
$10.2M472%N/AN/A
#10
$181.6M53813%N/AN/A
Add Company

What Is EcoNugenics?

Founded in 1995, ecoNugenics® is an innovative supplement company that provides targeted, high value nutraceutical supplements derived from nature, science and peer-reviewed research. Formulated by world-renowned physician, author and researcher, Isaac Eliaz, MD, MS, LAc, our unique nutraceutical products provide support for numerous areas of health. Our patented ingredients and proprietary blends are recommended by health practitioners worldwide. Our flagship product, PectaSol-C®, is the only clinically substantiated modified citrus pectin on the market with over 25 years of research and over 65 peer-reviewed studies.

keywords:N/A

N/A

Total Funding

24

Number of Employees

$4.5M

Revenue (est)

-11%

Employee Growth %

N/A

Valuation

N/A

Accelerator

Company NameRevenueNumber of EmployeesEmployee GrowthTotal Funding
#1
$2.6M2485%N/A
#2
$2.5M24-4%N/A
#3
$3.7M24-4%N/A
#4
$2.7M24-4%N/A
#5
N/A254%N/A